Device/Drug Borderline: Gray Areas Remain Despite New EU Guidance
Executive Summary
The regulation of products on the drug/device borderline has always been complex. New EU guidance aims to provide clarification, but some difficult and nuanced decision-making is still left to the manufacturer.
You may also be interested in...
First Polish Notified Body Designated Under The EU's Medical Device Regulation
The latest designation of a notified body in the context of the MDR means that the EU only needs one more to make the landmark total of 30. It seems that this may be realized soon.
EU Notified Body Figures Demonstrate The Scale And Timing Of Capacity Shortfall
Companies have been warned if they delay in applying for certification under the new Medical Device and IVD Regulations their products may not be reviewed in time. And the scale of the potential bottleneck is alarming.
Risk Management Standard Update Published Within Days For EU MDR Use
Medtech companies will soon be able to reference an updated European version of the international risk management standard when proving compliance with the EU Medical Device Regulation.